Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Oral misoprostol for induction of labour in hypertensive pregnancies

Oral misoprostol is simple to use and is thus an attractive and easy option in low-resource settings where the doctor–patient ratio is suboptimum and close monitoring of intravenous drug dosage is often not possible.1 Results of the PROBAAT-II study2 in women with a wide range of indications for induction of labour at term showed oral misoprostol treatment to be non-inferior to Foley catheterisation. Now, the findings of Shuchita Mundle and colleagues’ INFORM study3 in The Lancet advance the role of oral misoprostol for induction of labour.